News

US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...
STAT6d
Vaccine advisory panel recommends expanded RSV use, and two new vaccines
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...